Acute thrombocytopenia during alemtuzumab infusion in a patient with multiple sclerosis

被引：0
|
作者：
Di Carmine, C. [1 ]
Sciamanna, S. [1 ]
Cerrone, P. [1 ]
Carrocci, C. [1 ]
Marini, C. [1 ]
Carolei, A. [1 ]
Totaro, R. [1 ]
机构：
[1] Univ Aquila, Neurol, Laquila, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1487
引用
收藏
页码：776 / 776
页数：1
相关论文
共 50 条
  • [21] Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis
    Sega-Jazbec, Sasa
    Barun, Barbara
    Ledinek, Alenka Horvat
    Fabekovac, Visnja
    Skoric, Magdalena Krbot
    Habek, Mario
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 17 : 151 - 153
  • [22] Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment
    Barone, Stefania
    Scannapieco, Sara
    Torti, Carlo
    Filippelli, Enrica
    Pisani, Vincenzo
    Granata, Alfredo
    Console, Domenico
    Demonte, Giulio
    Tallarico, Tiziana
    Polidoro, Serena
    Quattrone, Aldo
    Valentino, Paola
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 20 : 6 - 8
  • [23] A case of severe Legionella pneumonia following alemtuzumab infusion for multiple sclerosis
    Spurgeon, Elizabeth N.
    Abbatemarco, Justin R.
    Miranda, Cyndee
    Rensel, Mary R.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 196
  • [24] Myocardial ischemia associated with alemtuzumab infusion in multiple sclerosis: a case report
    Camera, V.
    Ferraro, D.
    Vitetta, F.
    Zennaro, M.
    Simone, A. M.
    Nichelli, P. F.
    Sola, P.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 908 - 909
  • [25] Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis
    Jazbec, S. Sega
    Barun, B.
    Ledinek, A. Horvat
    Skoric, M. Krbot
    Habek, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 921 - 921
  • [26] A case of acute fulminant multiple sclerosis treated with alemtuzumab
    Gobbin, F.
    Marangi, A.
    Orlandi, R.
    Richelli, S.
    Turatti, M.
    Calabrese, M.
    Forgione, A.
    Alessandrini, F.
    Benedetti, M. D.
    Monaco, S.
    Gajofatto, A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 17 : 9 - 11
  • [27] Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment
    Barone, S.
    Scannapieco, S.
    Torti, C.
    Filippelli, E.
    Pisani, V.
    Granata, A.
    Console, D.
    Demonte, G.
    Tallarico, T.
    Polidoro, S.
    Quattrone, A.
    Valentino, P.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 640 - 641
  • [28] Alemtuzumab for multiple sclerosis
    不详
    LANCET, 2012, 380 (9856): : 1792 - 1792
  • [29] Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon
    Puthenparampil, Marco
    Rinaldi, Francesca
    Federle, Lisa
    Cazzola, Chiara
    Perini, Paola
    Gallo, Paolo
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 11 : 1 - 6
  • [30] Alemtuzumab for Multiple Sclerosis
    Mark D. Willis
    Neil P. Robertson
    Current Neurology and Neuroscience Reports, 2016, 16
12345